SC 13G/A: PROKIDNEY CORP.

AI Summary

SC 13G/A filing by PROKIDNEY CORP..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — er) Class A ordinary shares, par value $0.0001 per share (Titles of Class of Securit

Filing Documents

• s80143625.htm (SC 13G/A) — 75KB
• 0000899140-24-001094.txt ( ) — 77KB

(a)

Item 1(a). Name of Issuer: ProKidney Corp., a Cayman Islands exempted company limited by shares (the "Issuer").

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 2000 Frontis Plaza Blvd., Ste 250, Winston-Salem, NC 27103

(a)

Item 2(a). Name of Person Filing: This Amendment No. 3 to Schedule 13G is filed by Averill Master Fund, Ltd., an exempted company incorporated and existing under the laws of the Cayman Islands (the "Averill Fund"), Averill Madison Master Fund, Ltd., an exempted company incorporated and existing under the laws of the Cayman Islands (the "Averill Madison Fund"), Suvretta Capital Management, LLC ., a Delaware limited liability company (the "Manager"), and, Aaron Cowen, an individual ("Mr. Cowen" and, together with the Averill Fund, the Averill Madison Fund, and the Manager, the "Reporting Persons"). Mr. Cowen and the Manager may be deemed to beneficially own the Issuer Class A ordinary shares held by the Averill Fund and the Averill Madison Fund. Mr. Cowen may be deemed to control the Manager.

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: The principal business address of each of the Manager and Mr. Cowen is as follows: c/o Suvretta Capital Management, LLC 540 Madison Avenue, 7th Floor, New York, New York 10022. The principal business address of each of the Averill Fund and Averill Madison Fund is as follows: c/o Maples Corporate Services Limited P.O. Box 309 Ugland House Grand Cayman KY1-1104 Cayman Islands

(c)

Item 2(c). Citizenship: See responses to Item 4 on each cover page.

(d)

Item 2(d). Titles of Classes of Securities: Class A ordinary shares, par value $0.0001 per share ("Issuer Class A ordinary shares")

(e)

Item 2(e). CUSIP Number: The Issuer Class A ordinary shares CUSIP Number is G7S53R104. Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o). (b) Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c). (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c). (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) Investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). (f) Employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) Parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G). (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) Non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J). (k) Group in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ______________ . Item 4. (a) Amount beneficially owned: See responses to Item 9 on each cover page. (b) Percent of class: See responses to Item 11 on each cover page. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See responses to Item 5 on each cover page. (ii) Shared power to vote or to direct the vote: See responses to Item 6 on each cover page. (iii) Sole power to dispose or to direct the disposition of: See responses to Item 7 on each cover page. (iv) Shared power to dispose or to direct the disposition of: See responses to Item 8 on each cover page.

View Full Filing

View this SC 13G/A filing on SEC EDGAR